Belinda Sapanara
Nurse Practitioner · Monroeville, PANPI 1174813166
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $809 and has fallen 60.0% since, to $323 in 2025. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$418
- Amgen$363
- AstraZeneca$284
- Pfizer$276
- Bayer$155
- Actelion Pharmaceuticals US, Inc.$133
- plus $939 from 16 others
What the payments were for
- Food & beverage$2,568100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 25 | $418 |
| Amgen | 20 | $363 |
| AstraZeneca | 16 | $284 |
| Pfizer | 14 | $276 |
| Bayer | 7 | $155 |
| Actelion Pharmaceuticals US, Inc. | 6 | $133 |
| Impulse Dynamics (USA) Inc. | 4 | $121 |
| Johnson & Johnson | 8 | $113 |
| Novartis | 5 | $108 |
| Merck | 4 | $103 |
| Heartflow, Inc. | 5 | $101 |
| Alnylam Pharmaceuticals Inc. | 4 | $90 |
| Scpharmaceuticals Inc. | 2 | $52 |
| Boston Scientific | 2 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Boehringer Ingelheim | 2 | $38 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| Akcea Therapeutics, Inc. | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Cvrx, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $18 |
| United Therapeutics Corporation | 1 | $17 |
How this compares
$2,568 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Monroeville
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.